Research
Multimodality Scar Management Programme

  View Trial 1 (527kb PDF)

Research was undertaken to assess the efficacy of a multimodality (multi treatment) management regime used for the prevention of hypertrophic scars. ScarScience and the Scar Management Programme was investigated on consenting patients. The results below are from one of the sample groups using microporous tape alone and microporous tape with ScarScience.

Alan D. Widgerow, Laurence A. Chait, Pieter J. Stals, Rene Stals and Geoffrey Candy

Plastic Surgery Department, University of the Witwatersrand, Witwatersrand, South Africa, Department of Pharmaceutical Chemistry, North-West University, Potchefstroom, South Africa, Surgery Department, University of the Witwatersrand, Witwatersrand, South Africa

Published online: 2 December 2008 : International Aesthetic Plastic Surgery

Trial method:

3M Microporous tape was impregnated with a combination of agents (multimodal) to provide an occlusive dressing aimed at combating exaggerated scarring. The agents consisted of Centella asiatica, Bulbine frutescens, dimethicone (silicone) and oleuropein.

Trial assessment:

Results were assessed using a combination of techniques amalgamating Vancouver, Manchester and morphologic table systems together with patient and observer Scar Assessment Analyses. A comprehensive assessment of scar outcomes was undertaken and comparisons were made with control groups.

Trial results:

Treatment groups showed improvement outcomes in all variations of assessments. Final assessment at 6 months showed statistically significant scar outcomes in treatment groups.

Conclusion:

The multimodality approach to scar control showed significant benefits in the patient groups tested in this series.